Target- |
Mechanism- |
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date01 Jan 1928 |
Investigating the effect of Sarcomeal oral supplementation and vitamin D3 on muscle parameters and metabolic factors in patients with diabetic sarcopenia: a randomized open-label clinical trial with parallel groups
100 Clinical Results associated with Karen Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Karen Pharmaceutical Co. Ltd.
100 Deals associated with Karen Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Karen Pharmaceutical Co. Ltd.